Tissue progenitor cell (TPC)

Tissue progenitor cells are specialized, undifferentiated cells found within various adult tissues that serve as a critical reservoir for regeneration and repair. Unlike pluripotent stem cells, progenitor cells are typically multipotent or unipotent, meaning they are committed to differentiating into a specific lineage of cells to maintain tissue homeostasis or respond to injury (NIH, 2016). They reside in specific microenvironments known as niches, which regulate their activity through complex signaling pathways such as Wnt, Notch, and Hedgehog (Nature Reviews Molecular Cell Biology, 2017). In therapeutic contexts, these cells are not molecular targets themselves but are the biological entities modulated by drugs or used as cell-based therapies to treat degenerative diseases and hematopoietic disorders (PubMed, 2021). For example, growth factors like G-CSF are used to mobilize hematopoietic progenitor cells for bone marrow transplantation (StatPearls, 2023). However, the therapeutic use of progenitor cells carries risks, including the potential for malignant transformation into cancer stem cells or the formation of ectopic tissue (Journal of Clinical Investigation, 2018). Understanding the molecular markers and signaling requirements of these cells is essential for advancing regenerative medicine and oncology.

Other names

Adult stem cellSomatic stem cellPrecursor cellMultipotent progenitor cellTissue-specific stem cell

Drugs targeting tissue progenitor cells typically act by binding to surface receptors (e.g., G-CSFR, CXCR4) to stimulate mobilization from the bone marrow, promote proliferation, or induce differentiation into specific mature cell types to restore tissue function.